Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Twist Bioscience Corp - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
TWST
Nasdaq
2836
https://www.twistbioscience.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Twist Bioscience Corp
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
- Apr 18th, 2024 12:00 pm
Despite shrinking by US$135m in the past week, Twist Bioscience (NASDAQ:TWST) shareholders are still up 132% over 1 year
- Apr 5th, 2024 12:36 pm
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
- Mar 28th, 2024 12:00 pm
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
- Mar 5th, 2024 1:00 pm
Twist Bioscience to Present at Upcoming Investor Conferences
- Feb 22nd, 2024 1:00 pm
7 Stocks Cathie Wood Is Still Loading Up On in Q1
- Feb 13th, 2024 6:59 pm
Twist Bioscience Corp Director Robert Chess Sells 4,110 Shares
- Feb 10th, 2024 10:28 am
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Feb 7th, 2024 1:00 pm
Twist Bioscience Corporation (NASDAQ:TWST) Analysts Are Pretty Bullish On The Stock After Recent Results
- Feb 6th, 2024 7:26 pm
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
- Feb 6th, 2024 1:05 pm
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
- Feb 6th, 2024 1:00 pm
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2024 Earnings Call Transcript
- Feb 5th, 2024 1:09 pm
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
- Feb 5th, 2024 1:00 pm
Q1 2024 Twist Bioscience Corp Earnings Call
- Feb 3rd, 2024 4:42 am
Twist Bioscience Corp Reports Strong Revenue Growth in Q1 Fiscal 2024
- Feb 2nd, 2024 12:55 pm
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
- Feb 2nd, 2024 12:30 pm
Twist Bioscience Expands Express Genes Rapid Synthesis Service
- Jan 24th, 2024 1:00 pm
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
- Jan 16th, 2024 1:00 pm
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
- Jan 8th, 2024 1:00 pm
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
- Jan 5th, 2024 1:00 pm
Scroll